SCHEMBL20934678

SCHEMBL20934678

CCC(O)CC1CCNC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SLC6A1 P30531 2/20 0.42
▸ GABRA5 P31644 2/20 0.42
▸ GABRB2 P47870 2/20 0.42
▸ SLC6A12 P48065 2/20 0.42
▸ SLC6A11 P48066 2/20 0.42
▸ SLC6A13 Q9NSD5 2/20 0.42
▸ GABRA1 P14867 1/20 0.42
▸ GABRR1 P24046 1/20 0.42
▸ GABRA4 P48169 1/20 0.42
▸ CPN1 P15169 2/20 0.37
▸ CPB2 Q96IY4 2/20 0.37
▸ KCNH2 Q12809 1/20 0.35
▸ GNAI3 P08754 1/20 0.33
▸ GNAO1 P09471 1/20 0.33
▸ GNAI1 P63096 1/20 0.33
▸ HRH4 Q9H3N8 3/20 0.32
▸ HRH3 Q9Y5N1 3/20 0.32
▸ GBA1 P04062 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6050336 0.89 CPN1 (0.49) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL11256485 0.88 CPN1 (0.43) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL27959811 0.82 SLC6A1 (0.44) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL21743169 0.80 SLC6A1 (0.37) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL20028807 0.79 SLC6A1 (0.39) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL19476575 0.79 SLC6A1 (0.39) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL20027939 0.79 SLC6A1 (0.39) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL18756970 0.79 SLC6A1 (0.41) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL17315807 0.79 — —
SCHEMBL17315805 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019079607-A1 METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS Epizyme, Inc. (US) 2019-04-25 — — WO disclosed
Send feedback